文献速递瓣膜外科

经导管二尖瓣置换术后二尖瓣再手术:STS成人心脏外科数据库分析

Mitral Reoperation After Transcatheter Mitral Valve Replacement: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis.
PubMed 文献 · Ann Thorac Surg · 2025-07-07

基于STS数据库2013至2022年318例TMVR后再手术患者,分为瓣中瓣、环中瓣和自体瓣膜TMVR三组。再手术量逐年增加,总体手术死亡率高,自体瓣膜TMVR组死亡率最高达27.9%,择期手术在瓣中瓣和环中瓣组死亡率较低。

要点

  • TMVR后再手术罕见但逐年增加,2022年达75例。
  • 总体手术死亡率高,自体瓣膜TMVR组达27.9%。
  • 瓣中瓣和环中瓣组择期手术死亡率低于急诊手术。

核心结论

  • TMVR后再手术仍罕见但不断增加,手术高危且死亡率高,尤其自体瓣膜TMVR。
  • 缺乏TMVR后再介入明确数据,需透明咨询并审慎选择TMVR候选人。

研究设计与样本

  • 回顾性数据库分析,查询STS数据库2013至2022年TMVR后再手术患者,共318例。
  • 分为瓣中瓣TMVR组186例(58.5%)、环中瓣TMVR组71例(22.3%)和自体瓣膜TMVR组61例(19.2%)。

主要发现

  • 再手术由162个中心的283名外科医生完成,中位每医生1例、每中心1例。
  • 再手术量从2013年1例增至2022年75例;2022年同日开放转换仅1.3%(1/75)。
  • 总体中位年龄67岁,56.9%为急诊/紧急手术。

关键数值与推荐

  • 自体瓣膜TMVR再手术患者风险更高,年龄显著更大且多为急诊状态。
  • 有STS评分亚组中,预测死亡风险或观察与预期死亡比无组间差异。

临床怎么用

  • TMVR术后再手术应充分告知患者路径未明,并审慎选择TMVR适应人群。
  • 对瓣中瓣和环中瓣TMVR后再手术,择期手术可能降低死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the global interest in transcatheter mitral valve replacement (TMVR), mitral reoperation after TMVR has not been described. We aimed to delineate the features of post-TMVR reoperations. METHODS: We queried The Society of Thoracic Surgeons (STS) Database for post-TMVR reoperations from 2013 to 2022, identifying 318 patients for analysis. Patients were grouped into valve-in-valve-TMVR (n = 186 [58.5%]), valve-in-ring-TMVR (n = 71 [22.3%]), and native-TMVR (n = 61 [19.2%]). RESULTS: These reoperations were performed by 283 surgeons (median 1 case/surgeon) from 162 centers (median 1 case/center). The case volume increased from 1 in 2013 to 75 in 2022. Conversely, same-day open conversions during TMVR declined to only 1.3% (1 of 75 cases) in 2022. Overall, the median age was 67 years, and 56.9% were urgent/emergent. Native TMVR reoperations were generally higher risk, with patients being significantly older and most commonly emergent status. Operative mortality was 18.3%, 15.5%, and 27.9% in the valve-in-valve-TMVR, valve-in-ring-TMVR, and native-TMVR groups, respectively (P = .16). For the subgroup with an available STS score, the predicted risk of mortality or observed-to-expected mortality ratio did not differ by group. Elective procedures, compared with urgent/emergent procedures, demonstrated lower mortality in the valve-in-valve-TMVR (9.5% vs 26.0%; P = .002) and valve-in-ring-TMVR groups (8.3% vs 22.9%; P = .091), but not in the native-TMVR group (31.6% vs 26.2%, P = .66). CONCLUSIONS: Post-TMVR reoperations remain rare but are increasing, characterized by high acuity with corresponding high mortality, particularly native-TMVRs. In the absence of clear reintervention data after TMVR, transparent counseling of the undefined post-TMVR pathway and judicious TMVR candidate selections are necessary as TMVR practices expand globally.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Fukuhara S, Romano MA, Bolling SF, et al. Mitral Reoperation After Transcatheter Mitral Valve Replacement: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. Ann Thorac Surg. 2025. PMID: 40633601. doi:10.1016/j.athoracsur.2025.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。